Disease | hepatitis c |
Symptom | C0011847|diabetes |
Sentences | 26 |
PubMedID- 20558353 | The early recurrence, viremia and more severe fibrosis after antiviral therapy have an impact on the occurrence of new-onset diabetes in hepatitis c positive patients. |
PubMedID- 23049551 | Association of hepatitis c virus infection with type ii diabetes in ethiopia: a hospital-based case-control study. |
PubMedID- 22497813 | During the first nhanes cycle (1988-1994), insulin and diabetes were independently associated with hepatitis c. |
PubMedID- 24353540 | Most cross-sectional studies comparing the prevalence of diabetes in patients with chronic hepatitis c with that of a comparator group have shown that patients infected with hcv present with diabetes more often than patients with chronic liver diseases of other etiologies, even at a pre-cirrhotic stage.15 this observation was confirmed by a vast general population-based survey and by several longitudinal studies.16 most of the risk affects patients with other cofactors of diabetes, suggesting that hcv infection may significantly increase the rate of developing glucose metabolism alterations in predisposed individuals. |
PubMedID- 22418268 | Insulin resistance and diabetes mellitus in patients with chronic hepatitis c: spectators or actors. |
PubMedID- 22014765 | Visceral fat volume predicts new-onset type 2 diabetes in patients with chronic hepatitis c. |
PubMedID- 24523328 | When planning therapeutic interventions in chronic hepatitis c in patients with diabetes, it is considered the presence of visceral obesit , dyslipidemia, and hepatic steatosis. |
PubMedID- 26441826 | Observed that 63 out of 180 hepatitis c patients with pre-diabetes (34.8%) became normoglycemic after pegifnα–rbv therapy, while 10 (5.5%) developed dm (89). |
PubMedID- 20666689 | Nafld/nash and type 2 diabetes mellitus, along with hepatitis c virus infection, were the major etiologic risk factors associated with hcc. |
PubMedID- 22218030 | Moreover, this risk escalates if diabetes coincides with chronic hepatitis c and cirrhosis. |
PubMedID- 24500979 | Relationship of hepatitis c virus infection with diabetes in the u.s. |
PubMedID- 23984431 | Multiple mechanisms have been accounted for insulin resistance and development of diabetes in patients with chronic hepatitis c. it promotes ir mainly through interfering with insulin signaling pathway in hepatocytes, increasing inflammatory response with production of cytokines such as tnf alpha and il-6 and increasing oxidative stress . |
PubMedID- 21645344 | Several additional studies have also assessed the prevalence of type 2 diabetes mellitus in patients with chronic hepatitis c infection, affecting between 8 and 25% of these patients . |
PubMedID- 20040053 | Aim: the aim of this study was to investigate an association between antidiabetic therapies and the incidence of hcc in hepatitis c patients with diabetes mellitus. |
PubMedID- 22310786 | Impact of extrahepatic complications (diabetes and glomerulonephritis) associated with hepatitis c virus infection after renal transplantation. |
PubMedID- 22676360 | Although hepatitis c (hcv) is associated with diabetes, few studies have examined pre-diabetes in this population. |
PubMedID- 22701277 | diabetes in patients with chronic hepatitis c infection (chc) has unique and complex pathogenesis, which distinguishes this metabolic disorder from type 2 diabetes mellitus. |
PubMedID- PMC4034027 | Ifnα has been reported to induce symptoms of insulin-dependent type i diabetes in patients with chronic hepatitis c infection; for the most part in individuals with pre-existing autoimmunity and/or with a genetic predisposition . |
PubMedID- 22089377 | Occurrence of diabetes was not associated with hiv-related markers, hepatitis c, hypertension or family history of diabetes. |
PubMedID- 23909647 | Pre-existing hypertension, obesity, and diabetes increased the risk of dyslipidemia, whereas hepatitis c virus, lower cd4(+) t cell count, and higher hiv viral load had a protective effect. |
PubMedID- 20521408 | Results: the study included 1,283 subjects, 69.0% male, 39.7% injecting drug users, 19.5% hepatitis c infected, 6.5% with diabetes mellitus (dm-2), 11.6% had hypertension (htn) and 9.0% had kidney disease. |
PubMedID- 22014257 | Multiple co-morbidities including diabetes (23% of patients), hypertension (36%), hepatitis c (43%), and depression (74%) were concurrently managed. |
PubMedID- 21110426 | 4) the distribution of hcv genotypes in chronic hepatitis c patients with and without diabetes mellitus is not significantly different. |
PubMedID- 22245505 | We compared incidence of liver-related events and mortality rates between hepatitis c virus-positive patients with or without diabetes mellitus, and the incidence of diabetes-related events between diabetic patients with and without hepatitis c. |
PubMedID- 21270202 | Chronic hepatitis c is strongly associated with type 2 diabetes (7), whereas the occurrence of type 1 diabetes in chronic hepatitis c is almost always associated with the use of interferon (2–4). |
PubMedID- 24904670 | Berberine also effectively lowered fasting plasma glucose in chronic hepatitis b and hepatitis c patients with type 2 diabetes mellitus. |
Page: 1